This podcast episode of "The Compound and Friends" primarily discusses the market's reaction to President Trump's announced tariffs on Canada and Mexico, and the implications of a cheaper Chinese AI model, DeepSeek, on the US tech sector. The hosts and guests analyze the market's relatively calm response to the tariff news, attributing it to a lack of surprise given Trump's past actions and the understanding that it's a negotiating tactic. They also explore the potential impact of DeepSeek on established AI companies, suggesting that it could lead to increased efficiency and capital return for US tech giants. Finally, the panel discusses the potential for healthcare stocks to outperform as growth investors shift away from tech, citing January's market performance as evidence. A specific example is the discussion of Bristol-Myers Squibb as a potential investment opportunity within the healthcare sector.
